1 Here we have carried out the first genome-wide RNA-Sequencing
2 Here we have combined high-throughput immunophenotypic screen
3 Here we have demonstrated that temporary depletion of donor C
4 Here we have described a patient displaying a disorder charac
5 Here we have designed a novel class of engineered antibody-ba
6 Here we have discovered that norcoclaurine synthase from Thal
7 Here we have discovered that the bovine papillomavirus 1 (BPV
8 Here we have employed a primary rodent neuronal culture model
9 Here we have engineered and developmentally differentiated NK
10 Here we have examined CXCR4-CXCL12 interactions during the ma
11 Here we have extended these analyses to prenatal ages and add
12 Here we have investigated the role of non-muscle myosin II (n
13 Here we have performed a systematic and comparative analysis
14 Here we have quantitatively characterized the properties of c
15 Here we have shown that 3 nonsynonymous ITGAM variants that p
16 Here we have shown that CD47-signal regulatory protein alpha
17 Here we have shown that VHL-/- RCC cells rely on RC-derived a
18 Here we have simultaneously measured nociceptive behavior, br
19 Here we have systematically mapped and compared cleavage and
20 Here, we have addressed this question in the Gram-negative mo
21 Here, we have assessed the contribution of LRH-1 SUMOylation
22 Here, we have characterized nuclear and whole cell transcript
23 Here, we have demonstrated that mice deficient in C-type lect
24 Here, we have developed a novel computational method that all
25 Here, we have developed handheld spatially offset Raman spect
26 Here, we have developed thermally controllable, antibiotic-re
27 Here, we have elucidated the functional consequences of a NaV
28 Here, we have examined the contributions of conserved salt-br
29 Here, we have examined the host pathways by which vMIA traffi
30 Here, we have found that under homeostatic conditions, the mR
31 Here, we have generated a zebrafish model for ACR neurotoxici
32 Here, we have identified 2 unrelated families in the BRIDGE B
33 Here, we have identified 6 heterozygous truncating mutations
34 Here, we have identified and cloned a pollen-expressed P. rho
35 Here, we have identified T cell protein tyrosine phosphatase
36 Here, we have imaged fluorescently labeled AGs in live zebraf
37 Here, we have investigated whether DM1-associated muscle path
38 Here, we have profiled 2 repressive epigenetic marks, H3K9me2
39 Here, we have provided evidence that RANKL controls the expre
40 Here, we have purified the major E3 ubiquitin ligases from hu
41 Here, we have reported that Abeta is sufficient to acutely pr
42 Here, we have reported that neurite outgrowth from adult sens
43 Here, we have shown that blocking the activation of PERK usin
44 Here, we have solved the X-ray crystal structure of an EBNA1
45 Here, we have summarized recent advances that have been made
46 Here, we have undertaken crosslinking and other experiments t
47 Here, we have used mouse liver CRMs involved in regulatory ac
48 Here, we have used the epidermis as a model system to elucida
49 Here, we have used unnatural amino acid photo-cross-linking t
50 Here, we have utilized myoblasts isolated from FSHD patients